These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11170149)

  • 1. A monoclonal antibody cytolytic to androgen independent DU145 and PC3 human prostatic carcinoma cells.
    Talwar GP; Gupta R; Gupta SK; Malhotra R; Khanna R; Mitra DK; Sehgal S; Minz R; Kumar A
    Prostate; 2001 Feb; 46(3):207-13. PubMed ID: 11170149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A partner monoclonal antibody to Moab 730 kills 100% of DU145 and PC3 androgen-independent cancer cells.
    Vyas HK; Pal R; Lohiya NK; Talwar GP
    J Biosci; 2009 Dec; 34(6):909-16. PubMed ID: 20093744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
    Imai M; Ohta R; Varela JC; Song H; Tomlinson S
    Cancer Res; 2007 Oct; 67(19):9535-41. PubMed ID: 17909064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
    Kinouchi T; Bander NH; Kotake T
    J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker.
    Zhang G; Zhang H; Wang Q; Lal P; Carroll AM; de la Llera-Moya M; Xu X; Greene MI
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):732-7. PubMed ID: 20080743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) in human prostate cancer.
    Jarvis GA; Li J; Hakulinen J; Brady KA; Nordling S; Dahiya R; Meri S
    Int J Cancer; 1997 Jun; 71(6):1049-55. PubMed ID: 9185710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dexamethasone on human mucin 1 expression and antibody-dependent complement sensitivity in a prostate cancer cell line in vitro and in vivo.
    Imai M; Hwang HY; Norris JS; Tomlinson S
    Immunology; 2004 Mar; 111(3):291-7. PubMed ID: 15009429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of an enhanced prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer.
    Theoret MR; Arlen PM; Pazdur M; Dahut WL; Schlom J; Gulley JL
    Clin Genitourin Cancer; 2007 Jun; 5(5):347-50. PubMed ID: 17645835
    [No Abstract]   [Full Text] [Related]  

  • 9. The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma.
    Prewett M; Rockwell P; Rockwell RF; Giorgio NA; Mendelsohn J; Scher HI; Goldstein NI
    J Immunother Emphasis Tumor Immunol; 1996 Nov; 19(6):419-27. PubMed ID: 9041461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
    Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
    Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and characterization of a monoclonal antibody which recognizes a new prostate-organ specific antigen].
    Ka S; Eto H; Arakawa S; Kamidono S
    Nihon Hinyokika Gakkai Zasshi; 1999 Sep; 90(9):790-7. PubMed ID: 10517088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-defined antigens of human prostate cancer cell line PC3.
    Lindgren J; Blaszczyk M; Atkinson B; Steplewski Z; Koprowski H
    Cancer Immunol Immunother; 1986; 22(1):1-7. PubMed ID: 3518928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared antigens of human prostate cancer cell lines as defined by monoclonal antibodies.
    Lindgren J; Pak KY; Ernst C; Rovera G; Steplewski Z; Koprowski H
    Hybridoma; 1985; 4(1):37-45. PubMed ID: 3881336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of monoclonal antibody against androgen receptor.
    Demura T; Kuzumaki N; Oda A; Fujita H; Ishibashi T; Koyanagi T
    J Steroid Biochem; 1989 Nov; 33(5):845-51. PubMed ID: 2689792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
    Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer.
    Kinoshita Y; Kuratsukuri K; Newman N; Rovito PM; Kaumaya PT; Wang CY; Haas GP
    Prostate Cancer Prostatic Dis; 2005; 8(4):359-63. PubMed ID: 16172607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L6 monoclonal antibody binds prostate cancer.
    O'Donnell RT; DeNardo SJ; Shi XB; Mirick GR; DeNardo GL; Kroger LA; Meyers FJ
    Prostate; 1998 Oct; 37(2):91-7. PubMed ID: 9759703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS; Morgan AC
    Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.